Share the post "Coral Laboratories ‘s Q1 Financial results: Revenue Grows by 133.68% YoY"
Highlights
- The presented financial data is Standalone to provide a comprehensive overview of the company performance.
- Sales over the Year and quarter: The company experienced a substantial growth of 133.68 % in the past year, substantial increase in net sales/revenue by 9.59 %.
- Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 20.91 %. Marginal decrease of -22.03% in other income during this quarter.
- Profit over the Year and quarter: Significant improvement in profitability for Coral Laboratories Ltd.. Notable increase of 378.01 % in net profit Year to Year, Coral Laboratories Ltd.’s profitability increased by 52.15 % in this quarter.
- EPS over the Year and quarter: EPS increased by 377.52 % Year to Year. EPS increased by 52.1 % in previous quarter. Positive impact on shareholders.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 13.547 Cr | Rs. 28.886 Cr | Rs. 31.656 Cr | + 9.59 % | + 133.68 % |
| Expenses | Rs. 11.81 Cr | Rs. 22.64 Cr | Rs. 20.92 Cr | -7.6 % | + 77.14 % |
| Operating Profit | Rs. 1.74 Cr | Rs. 6.25 Cr | Rs. 10.74 Cr | + 71.84 % | + 517.24 % |
| OPM % | 12.84 % | 21.64 % | 33.93 % | + 12.29 % | + 21.09 % |
| Other Income | Rs. 1.291 Cr | Rs. 2.002 Cr | Rs. 1.561 Cr | -22.03 % | + 20.91 % |
| Interest | Rs. 0 Cr | Rs. 0 Cr | Rs. 0.03 Cr | 0 % | 0 % |
| Depreciation | Rs. 0.55 Cr | Rs. 0.5 Cr | Rs. 0.49 Cr | -2 % | -10.91 % |
| Profit before tax | Rs. 2.48 Cr | Rs. 7.75 Cr | Rs. 11.78 Cr | + 52 % | + 375 % |
| Tax % | 25.93 % | 25.28 % | 25.22 % | -0.06 % | -0.71 % |
| Net Profit | Rs. 1.84 Cr | Rs. 5.79 Cr | Rs. 8.81 Cr | + 52.16 % | + 378.8 % |
| EPS in Rs | Rs. 5.16 | Rs. 16.2 | Rs. 24.64 | + 52.1 % | + 377.52 % |
Today, we’re looking at Coral Laboratories Ltd.’s financial performance for the Q1(Jun 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 133.68 %. However, it did see a marginal increase of 9.59 % from the previous quarter. Expenses decreased slightly by -7.6 % quarter-on-quarter, aligning with the annual rise of 77.14 %. Operating profit, while up 517.24 % compared to last year, faced a quarter-on-quarter increase of 71.84 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 21.09 %, but an expansion of 12.29 % sequentially. Other income fell by -22.03 % compared to the last quarter, despite an annual growth of 20.91 %. Depreciation costs fell by -2 % quarter-on-quarter, yet on an annual scale, they experienced a reduction of -10.91 %. Profit before tax grew annually by 375 % but saw an increase from the preceding quarter by 52 %.
Tax expenses as a percentage of profits decreased slightly by -0.71 % compared to last year, with a more notable quarter-on-quarter decrease of -0.06 %. Net profit rose by 378.8 % year-on-year but experienced a 52.16 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 377.52 % but a quarterly rise of 52.1 %. In summary, Coral Laboratories Ltd.’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 13.547 Cr | Rs. 28.886 Cr | Rs. 31.656 Cr | + 9.59 % | + 133.68 % |
| Expenses | Rs. 11.81 Cr | Rs. 22.64 Cr | Rs. 20.92 Cr | -7.6 % | + 77.14 % |
| Operating Profit | Rs. 1.74 Cr | Rs. 6.25 Cr | Rs. 10.74 Cr | + 71.84 % | + 517.24 % |
| Net Profit | Rs. 1.84 Cr | Rs. 5.79 Cr | Rs. 8.81 Cr | + 52.16 % | + 378.8 % |
| EPS in Rs | Rs. 5.16 | Rs. 16.2 | Rs. 24.64 | + 52.1 % | + 377.52 % |
In reviewing Coral Laboratories Ltd.’s 2024(Q1) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 133.68 % year-on-year growth, however, there was a minor increase of 9.59 % from the previous quarter. Expenses rose by 77.14 % compared to the previous year, with a decrease of -7.6 % quarter-on-quarter. Operating Profit surged by 517.24 % annually, and saw a 71.84 % increase from the last quarter.
Net Profit showed yearly increase of 378.8 %, and experienced a 52.16 % increase from the previous quarter. Earnings Per Share (EPS) rose by 377.52 % annually, however rose by 52.1 % compared to the last quarter. In essence, while Coral Laboratories Ltd. exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
